GOAL 2030: ACCESS FOR ALL

GENERATING A HEALTHY MEDICINES STRATEGY FOR THE NEXT DECADE

Join us for the Medicines for Europe and IGBA Conference* in Athens to shape the 2030 agenda for the off-patent industry

A rich agenda will draw lessons from the pandemic and look towards the future of the industry:

It is well-known that a cancer diagnosis and its sometimes long-lasting treatment can impair the sexual life of patients and survivors. This contributes to a deterioration of their quality of life and can also lead to an alteration of their therapeutic adhesion and therefore of their prognosis.

In the context of the COVID-19 pandemic, influenza vaccination has demonstrated its great value to public health as an essential measure to protect vulnerable groups and national healthcare systems from added pressure. Despite this however, there is still a lot of work that needs to be done to increase vaccine uptake across Europe, to ensure we recover from this pandemic and continue to protect more Europeans from Influenza in the future.